Anna Mowry, CFO and Treasurer at Nautilus Biotechnology, Inc. (NAUT), bought 17,500 shares at $2.30 ($40K) on 2022-08-19, disclosed to the SEC on 2022-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| NAUT | BUY | 2021-11-24 | $69K | — | Filing → |
| NAUT | BUY | 2021-08-16 | $135K | — | Filing → |